What are the limitations of the wells score dvt?

While the wells score dvt is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the wells score dvt to ensure safe bedside use and optimal diagnostic accuracy.

How does the wells score dvt compare to other hematology scores?

The wells score dvt is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the wells score dvt free to use?

Yes. OpiCalc provides the wells score dvt completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

Wells Score (DVT)

DVT Pretest Probability: Combines physical signs and history. A score of ≤ 0 with a negative D-dimer effectively rules out DVT (likelihood < 1%).

Baseline & Physical Signs

Wells DVT Probability

0

Class

Low Risk

~3% Prevalence in Class

Next Clinical Step

Rule out with D-dimer

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing the pretest probability of DVT in symptomatic patients.

Combined with D-dimer testing to rule out DVT without imaging (in low/moderate risk groups).

Selecting patients who require urgent venous duplex ultrasonography.

The 'Safe Rule-out'

Patients with a Wells Score ≤ 0 AND a negative high-sensitivity D-dimer have < 1% likelihood of DVT and do not require imaging.

Section 2

Formula & Logic

Risk Factors (1 pt each)

Active cancer (treatment ongoing, or within previous 6 months or palliative).

Paralysis, paresis, or recent plaster immobilization of the lower extremities.

Recently bedridden > 3 days or major surgery within 12 weeks requiring GA or spinal anesthesia.

Localized tenderness along the distribution of the deep venous system.

Entire leg swollen.

Calf swelling > 3 cm larger than asymptomatic side (measured 10 cm below tibial tuberosity).

Pitting edema confined to the symptomatic leg.

Collateral superficial veins (non-varicose).

Previously documented DVT.

Protective Factor (-2 pts)

Alternative diagnosis is at least as likely as DVT (e.g., Baker's cyst, cellulitis, muscle strain).

Thresholds

Score	Probability Level	Prevalence of DVT
≤ 0	Low Probability	3%
1 - 2	Moderate Probability	17%
≥ 3	High Probability	75%

Section 3

Pearls/Pitfalls

The Differential Penalty

The -2 point "Alternative Diagnosis" penalty is the most subjective part of the score. Clinicians should be confident in an specific alternative (like a clear rupture of a Baker's cyst) before applying this deduction.

Anticoagulation Timing

In patients with high probability (Wells ≥ 3), consider initiating empirical anticoagulation while awaiting ultrasound if the study cannot be performed on the same day.

Section 4

Evidence Appraisal

Primary Strategy

Value of assessment of pretest probability of deep-vein thrombosis in clinical management.

Wells PS et al. • The Lancet. 1997;350(9094):1795-8.

View Source

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Wells PS et al. • NEJM. 2003;349(13):1227-35.

View Source

Section 5

Literature

History

Developed by Dr. Philip Wells at the University of Ottawa. It remains the most widely validated and utilized clinical decision rule in thrombosis medicine.

Last Comprehensive Review: 2026

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing the pretest probability of DVT in symptomatic patients.

Combined with D-dimer testing to rule out DVT without imaging (in low/moderate risk groups).

Selecting patients who require urgent venous duplex ultrasonography.

The 'Safe Rule-out'

Patients with a Wells Score ≤ 0 AND a negative high-sensitivity D-dimer have < 1% likelihood of DVT and do not require imaging.

Section 2

Formula & Logic

Risk Factors (1 pt each)

Active cancer (treatment ongoing, or within previous 6 months or palliative).

Paralysis, paresis, or recent plaster immobilization of the lower extremities.

Recently bedridden > 3 days or major surgery within 12 weeks requiring GA or spinal anesthesia.

Localized tenderness along the distribution of the deep venous system.

Entire leg swollen.

Calf swelling > 3 cm larger than asymptomatic side (measured 10 cm below tibial tuberosity).

Pitting edema confined to the symptomatic leg.

Collateral superficial veins (non-varicose).

Previously documented DVT.

Protective Factor (-2 pts)

Alternative diagnosis is at least as likely as DVT (e.g., Baker's cyst, cellulitis, muscle strain).

Thresholds

Score	Probability Level	Prevalence of DVT
≤ 0	Low Probability	3%
1 - 2	Moderate Probability	17%
≥ 3	High Probability	75%

Section 3

Pearls/Pitfalls

The Differential Penalty

Anticoagulation Timing

In patients with high probability (Wells ≥ 3), consider initiating empirical anticoagulation while awaiting ultrasound if the study cannot be performed on the same day.

Section 4

Evidence Appraisal

Primary Strategy

Value of assessment of pretest probability of deep-vein thrombosis in clinical management.

Wells PS et al. • The Lancet. 1997;350(9094):1795-8.

View Source

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Wells PS et al. • NEJM. 2003;349(13):1227-35.

View Source

Section 5

Literature

History

Developed by Dr. Philip Wells at the University of Ottawa. It remains the most widely validated and utilized clinical decision rule in thrombosis medicine.

Last Comprehensive Review: 2026

Related Hematology Tools

PNH Clone Size Interpreter

LDH/AST Ratio

ISTH Bleeding Assessment Tool

PBT

von Willebrand Factor Activity Interpreter

Haemophilia Severity Classification

Factor Inhibitor Bethesda Titre Interpreter

ISTH Non-Overt DIC Score

Mixing Study Interpretation

Lupus Anticoagulant

Have feedback about this calculator?Let us know.

Wells Score (DVT)

DVT Pretest Probability: Combines physical signs and history. A score of ≤ 0 with a negative D-dimer effectively rules out DVT (likelihood < 1%).

Baseline & Physical Signs

Wells DVT Probability

0

Class

Low Risk

~3% Prevalence in Class

Next Clinical Step

Rule out with D-dimer

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing the pretest probability of DVT in symptomatic patients.

Combined with D-dimer testing to rule out DVT without imaging (in low/moderate risk groups).

Selecting patients who require urgent venous duplex ultrasonography.

The 'Safe Rule-out'

Patients with a Wells Score ≤ 0 AND a negative high-sensitivity D-dimer have < 1% likelihood of DVT and do not require imaging.

Section 2

Formula & Logic

Risk Factors (1 pt each)

Active cancer (treatment ongoing, or within previous 6 months or palliative).

Paralysis, paresis, or recent plaster immobilization of the lower extremities.

Recently bedridden > 3 days or major surgery within 12 weeks requiring GA or spinal anesthesia.

Localized tenderness along the distribution of the deep venous system.

Entire leg swollen.

Calf swelling > 3 cm larger than asymptomatic side (measured 10 cm below tibial tuberosity).

Pitting edema confined to the symptomatic leg.

Collateral superficial veins (non-varicose).

Previously documented DVT.

Protective Factor (-2 pts)

Alternative diagnosis is at least as likely as DVT (e.g., Baker's cyst, cellulitis, muscle strain).

Thresholds

Score	Probability Level	Prevalence of DVT
≤ 0	Low Probability	3%
1 - 2	Moderate Probability	17%
≥ 3	High Probability	75%

Section 3

Pearls/Pitfalls

The Differential Penalty

Anticoagulation Timing

In patients with high probability (Wells ≥ 3), consider initiating empirical anticoagulation while awaiting ultrasound if the study cannot be performed on the same day.

Section 4

Evidence Appraisal

Primary Strategy

Value of assessment of pretest probability of deep-vein thrombosis in clinical management.

Wells PS et al. • The Lancet. 1997;350(9094):1795-8.

View Source

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Wells PS et al. • NEJM. 2003;349(13):1227-35.

View Source

Section 5

Literature

History

Developed by Dr. Philip Wells at the University of Ottawa. It remains the most widely validated and utilized clinical decision rule in thrombosis medicine.

Last Comprehensive Review: 2026

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing the pretest probability of DVT in symptomatic patients.

Combined with D-dimer testing to rule out DVT without imaging (in low/moderate risk groups).

Selecting patients who require urgent venous duplex ultrasonography.

The 'Safe Rule-out'

Patients with a Wells Score ≤ 0 AND a negative high-sensitivity D-dimer have < 1% likelihood of DVT and do not require imaging.

Section 2

Formula & Logic

Risk Factors (1 pt each)

Active cancer (treatment ongoing, or within previous 6 months or palliative).

Paralysis, paresis, or recent plaster immobilization of the lower extremities.

Recently bedridden > 3 days or major surgery within 12 weeks requiring GA or spinal anesthesia.

Localized tenderness along the distribution of the deep venous system.

Entire leg swollen.

Calf swelling > 3 cm larger than asymptomatic side (measured 10 cm below tibial tuberosity).

Pitting edema confined to the symptomatic leg.

Collateral superficial veins (non-varicose).

Previously documented DVT.

Protective Factor (-2 pts)

Alternative diagnosis is at least as likely as DVT (e.g., Baker's cyst, cellulitis, muscle strain).

Thresholds

Score	Probability Level	Prevalence of DVT
≤ 0	Low Probability	3%
1 - 2	Moderate Probability	17%
≥ 3	High Probability	75%

Section 3

Pearls/Pitfalls

The Differential Penalty

Anticoagulation Timing

In patients with high probability (Wells ≥ 3), consider initiating empirical anticoagulation while awaiting ultrasound if the study cannot be performed on the same day.

Section 4

Evidence Appraisal

Primary Strategy

Value of assessment of pretest probability of deep-vein thrombosis in clinical management.

Wells PS et al. • The Lancet. 1997;350(9094):1795-8.

View Source

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Wells PS et al. • NEJM. 2003;349(13):1227-35.

View Source

Section 5

Literature

History

Developed by Dr. Philip Wells at the University of Ottawa. It remains the most widely validated and utilized clinical decision rule in thrombosis medicine.

Last Comprehensive Review: 2026

Related Hematology Tools

PNH Clone Size Interpreter

LDH/AST Ratio

ISTH Bleeding Assessment Tool

PBT

von Willebrand Factor Activity Interpreter

Haemophilia Severity Classification

Factor Inhibitor Bethesda Titre Interpreter

ISTH Non-Overt DIC Score

Mixing Study Interpretation

Lupus Anticoagulant

Have feedback about this calculator?Let us know.